Harrow, Inc. (HROW) vs Perrigo Company plc (PRGO)
Harrow, Inc. and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.1B against $1.2B — 1.7× the size. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against −4.19%. Harrow, Inc. has the higher net margin (−13.5% vs −41.9%) and the higher return on invested capital (−0.77% vs −18.1%). Across the 18 metrics below, Harrow, Inc. leads on 9 and Perrigo Company plc on 9.
Valuation
Profitability
| Metric | HROW | PRGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 73.28% | 33.26% | 53.94% |
| Operating margin | (1.00%) | (37.71%) | 0.00% |
| Net margin | (13.51%) | (41.85%) | 0.00% |
| Free cash flow margin | (4.75%) | 2.88% | 0.00% |
| Return on equity | (116.07%) | (49.65%) | (0.40%) |
| Return on assets | (9.77%) | (19.60%) | (3.32%) |
| Return on invested capital | (0.77%) | (18.06%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack